Posters

Clinical outcomes of Mini WELL Ready IOL for Asian patients

Poster Details

First Author: S.Noguchi JAPAN

Co Author(s):                        

Abstract Details

Purpose:

To study early clinical results of Miniwell Ready�Â�® in Japan, and compere to several bifocal, trifocal, and refractive multifocal IOL about visual function and secondary symptom.

Setting:

Patients who underwent cataract surgery with multifocal intraocular lens (Miniwell, LS-313 MF30, Pod F, ZMB00, ZKB00, ZXR00V) in 2016.

Methods:

All cases were recived checks which consist of distance (5m), intrmidiet(70cm) ,and near(30cm) visual acuity test, contrast, Questionnaire on multifocal secondary symptoms(QoV : quality of vision) in 3 months after surgery, and questionnaire on the presence of secondary symptoms in night driving (QoV) were performed. We also conducted similar tests for ZMB 00 (AMO), ZKB 00 (AMO), Pod F (fine vision), MF 30 T (Lentis M plus X), ZX R00V (AMO).

Results:

The seven pateints were inplanted with Miniwell�Â�®. All cases were 1.9mm transconjunctival screlocorneal incision and could be implanted sefely. The average uncorrected distance visual acuity was 0 (logMAR). The average near visual acuity was 0.23, and the corrected near visual acuity was 0.17. There was no significant difference compared with the contrast monofocal lens. Secondary symptoms observed in multifocal intraocular lenses were very few. (Halo score of QoV were 0(Miniwell), 0.78(MF30) 1.51(PodF) 1.49(ZKB00), 1.82(ZMB00), 1.10(ZXR00V). Multiple image score of Qov were 0.10(Miniwell), 0.56(MF30) 0.23(PodF) 0.13(ZKB00), 0.15(ZMB00), 0.12(ZXR00V)). For ZMB00, ZKB00, PodF, ZXR00, Hello's awareness was strong.

Conclusions:

It is suggested that it may be a tool that can improve patient satisfaction although there are few secondary symptoms although it is somewhat weaker visual acuity than bifocal, trifocal multifocal intraocular lens. It is important to understand and use properly the characteristics of each multifocal intraocular lens in order to raise patient satisfaction and not to complain.

Financial Disclosure:

NONE